COMPANY
Immorta Bio
Funding and NIH signals
- SEC Form D raise Form D reports $613K sold since 2024 (filed Oct 16, 2026); +1 other Form D filing in the last 12 months. SEC Form D 0002102665-26-000002 (Oct 16, 2026)
Evidence (2 events)
- Oct 16, 2026 · SEC Form D 0002102665-26-000002
Name of Issuer: Immorta Bio, Inc.; CIK: 2102665; Address: Miami Beach, FL; Submission type: D; Filing date: 2026-10-16; Industry Group: Biotechnology; Date of First Sale: 2024-11-05; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 5000000; Total Amount Sold: 612503; Federal exemptions: 06c - Jan 8, 2026 · SEC Form D 0002102665-26-000001
Name of Issuer: Immorta Bio, Inc.; CIK: 2102665; Address: Miami Beach, FL; Submission type: D; Filing date: 2026-01-08; Industry Group: Biotechnology; Date of First Sale: 2023-11-09; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 500000; Total Amount Sold: 450000; Federal exemptions: 06c
- Oct 16, 2026 · SEC Form D 0002102665-26-000002